The Scientist

» industry

Most Recent

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

0 Comments

image: TS Live: Pharma Feast

TS Live: Pharma Feast

By | August 26, 2015

A sampling of the biggest acquisitions reshaping the life sciences industry in 2015

0 Comments

image: Drugging the Environment

Drugging the Environment

By | August 1, 2015

Humans have spiked ecosystems with a flood of active pharmaceuticals. The drugs are feminizing male fish, confusing birds, and worrying scientists.

5 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Follow the Funding

Follow the Funding

By | May 1, 2015

In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.  

8 Comments

image: Think Before You Fire

Think Before You Fire

By | May 1, 2015

Industry layoffs may save a few dollars, at the cost of losing the collective brainpower of thousands of scientists.

4 Comments

image: Drugmaker Teva Bids $40 Billion for Mylan

Drugmaker Teva Bids $40 Billion for Mylan

By | April 23, 2015

The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.

0 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Mitochondria Exchange
    News Analysis Mitochondria Exchange

    A decade of research on intercellular mitochondrial transfer has answered some long-standing questions and raised new ones.

  4. Opinion: Engineering the Epigenome
Advertisement
ProteinSimple
ProteinSimple
Advertisement